Effect of Deep Brain Stimulation on the Severity of Seizures and the Quality of Life in Patients with Multifocal Drug-resistant Epilepsy in Iran: A Pilot Review of Local Experience

Overview

Journal Epilepsy Behav Rep

Date 2025 Feb 5

PMID 39906530

Authors

Amir Reza Bahadori

Parisa Javadnia

Afshan Davari

Sajad Shafiee

Sara Ranji

Mehrdad Sheikhvatan

Abbas Tafakhori

Affiliations

Soon will be listed here.

Abstract

This study investigates the impact of the anterior nucleus of the thalamus deep brain stimulation (ANT-DBS) on patients with drug-resistant epilepsy (DRE) in Iran, specifically focusing on its effects on seizure metrics, severity and its influence on quality of life over time. A cohort of eight patients with DRE in Iran who underwent ANT-DBS was evaluated. Pre-operative assessments included comprehensive documentation of seizure frequency, duration, severity scores, and the Quality of Life in Epilepsy Inventory (QOLIE-13). Each patient also underwent high-resolution imaging using a 1.5 Tesla MRI, with targeted electrode placement in the anterior thalamic area. Post-operative evaluations measured changes in seizure frequency, severity scores, duration, and quality of life indicators. All subjects presented with DRE, and the mean age of participants was 24.62 years. Post-operative data revealed significantly reduced seizure frequency, duration, and severity scores. Notably, this reduction was more pronounced at the 6-month follow-up than the 3-month assessment, indicating a progressive therapeutic effect. All patients demonstrated a response to ANT-DBS, with two individuals achieving seizure freedom. Additionally, there was a marked improvement in quality of life, particularly in the domains of energy/fatigue and social functioning. ANT-DBS has been established as a promising and safe therapeutic intervention for patients with DRE. In a cohort of DRE patients in Iran, the treatment demonstrated comparable efficacy in decreasing seizure frequency and severity and enhancing self-reported quality of life, consistent with findings reported in the existing literature. The therapeutic benefits of ANT-DBS appear to augment over time.

References

Park H, Choi S, Joo E, Seo D, Bong Hong S, Lee J . The Role of Anterior Thalamic Deep Brain Stimulation as an Alternative Therapy in Patients with Previously Failed Vagus Nerve Stimulation for Refractory Epilepsy. Stereotact Funct Neurosurg. 2019; 97(3):176-182. DOI: 10.1159/000502344. View

Krishna V, King N, Sammartino F, Strauss I, Andrade D, Wennberg R . Anterior Nucleus Deep Brain Stimulation for Refractory Epilepsy: Insights Into Patterns of Seizure Control and Efficacious Target. Neurosurgery. 2016; 78(6):802-11. DOI: 10.1227/NEU.0000000000001197. View

Alcala-Zermeno J, Gregg N, Starnes K, Mandrekar J, Van Gompel J, Miller K . Invasive neuromodulation for epilepsy: Comparison of multiple approaches from a single center. Epilepsy Behav. 2022; 137(Pt A):108951. PMC: 9934010. DOI: 10.1016/j.yebeh.2022.108951. View

Saadi A, Patenaude B, Mateen F . Quality of life in epilepsy-31 inventory (QOLIE-31) scores: A global comparison. Epilepsy Behav. 2016; 65:13-17. DOI: 10.1016/j.yebeh.2016.09.032. View

Poulen G, Rolland A, Chan-Seng E, Sanrey E, Gelisse P, Crespel A . Microendoscopic transventricular deep brain stimulation of the anterior nucleus of the thalamus as a safe treatment in intractable epilepsy: A feasibility study. Rev Neurol (Paris). 2022; 178(9):886-895. DOI: 10.1016/j.neurol.2022.03.023. View

Sitnikov A, Grigoryan Y, Mishnyakova L . Bilateral stereotactic lesions and chronic stimulation of the anterior thalamic nuclei for treatment of pharmacoresistant epilepsy. Surg Neurol Int. 2018; 9:137. PMC: 6069370. DOI: 10.4103/sni.sni_25_18. View

Tyvaert L, Chassagnon S, Sadikot A, LeVan P, Dubeau F, Gotman J . Thalamic nuclei activity in idiopathic generalized epilepsy: an EEG-fMRI study. Neurology. 2009; 73(23):2018-22. DOI: 10.1212/WNL.0b013e3181c55d02. View

Wang S, Zhao M, Li T, Zhang C, Zhou J, Wang M . Long-term efficacy and cognitive effects of bilateral hippocampal deep brain stimulation in patients with drug-resistant temporal lobe epilepsy. Neurol Sci. 2020; 42(1):225-233. DOI: 10.1007/s10072-020-04554-8. View

Salanova V, Sperling M, Gross R, Irwin C, Vollhaber J, Giftakis J . The SANTÉ study at 10 years of follow-up: Effectiveness, safety, and sudden unexpected death in epilepsy. Epilepsia. 2021; 62(6):1306-1317. DOI: 10.1111/epi.16895. View

10.

Hodaie M, Wennberg R, Dostrovsky J, Lozano A . Chronic anterior thalamus stimulation for intractable epilepsy. Epilepsia. 2002; 43(6):603-8. DOI: 10.1046/j.1528-1157.2002.26001.x. View

11.

Yan H, Wang X, Zhang X, Qiao L, Gao R, Ni D . Deep brain stimulation for patients with refractory epilepsy: nuclei selection and surgical outcome. Front Neurol. 2023; 14:1169105. PMC: 10213517. DOI: 10.3389/fneur.2023.1169105. View

12.

Kaufmann E, Bartolomei F, Boon P, Chabardes S, Colon A, Eross L . European Expert Opinion on ANT-DBS therapy for patients with drug-resistant epilepsy (a Delphi consensus). Seizure. 2020; 81:201-209. DOI: 10.1016/j.seizure.2020.08.015. View

13.

Marson A, Al-Kharusi A, Alwaidh M, Appleton R, Baker G, Chadwick D . The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet. 2007; 369(9566):1016-26. PMC: 2039891. DOI: 10.1016/S0140-6736(07)60461-9. View

14.

Kim S, Lim S, Kim J, Son B, Lee K, Shon Y . Long-term follow-up of anterior thalamic deep brain stimulation in epilepsy: A 11-year, single center experience. Seizure. 2017; 52:154-161. DOI: 10.1016/j.seizure.2017.10.009. View

15.

Zaccara G, Citerio G, Del Gaudio A, Ferlisi M, Pugliese F, Toni D . Clinical pathways of epileptic seizures and status epilepticus: results from a survey in Italy. Neurol Sci. 2020; 41(6):1571-1575. PMC: 7275936. DOI: 10.1007/s10072-020-04270-3. View

16.

Lee K, Shon Y, Cho C . Long-term outcome of anterior thalamic nucleus stimulation for intractable epilepsy. Stereotact Funct Neurosurg. 2012; 90(6):379-85. DOI: 10.1159/000339991. View

17.

Zangiabadi N, Ladino L, Sina F, Pablo Orozco-Hernandez J, Carter A, Tellez-Zenteno J . Deep Brain Stimulation and Drug-Resistant Epilepsy: A Review of the Literature. Front Neurol. 2019; 10:601. PMC: 6563690. DOI: 10.3389/fneur.2019.00601. View

18.

Andrade D, Hamani C, Lozano A, Wennberg R . Dravet syndrome and deep brain stimulation: seizure control after 10 years of treatment. Epilepsia. 2009; 51(7):1314-6. DOI: 10.1111/j.1528-1167.2009.02408.x. View

19.

Kerrigan J, Litt B, Fisher R, Cranstoun S, French J, Blum D . Electrical stimulation of the anterior nucleus of the thalamus for the treatment of intractable epilepsy. Epilepsia. 2004; 45(4):346-54. DOI: 10.1111/j.0013-9580.2004.01304.x. View

20.

Tellez-Zenteno J, Dhar R, Wiebe S . Long-term seizure outcomes following epilepsy surgery: a systematic review and meta-analysis. Brain. 2005; 128(Pt 5):1188-98. DOI: 10.1093/brain/awh449. View